The aim of the present work is to
synthesize, characterize, and
test self-assembled anisotropic or Janus particles designed to load
anticancer drugs for lung cancer treatment by inhalation. The particles
were synthesized using binary mixtures of biodegradable and biocompatible
materials. The particles did not demonstrate cyto- and genotoxic effects.
Janus particles were internalized by cancer cells and accumulated
both in the cytoplasm and nuclei. After inhalation delivery, nanoparticles
accumulated preferentially in the lungs of mice and retained there
for at least 24 h. Two drugs or other biologically active components
with substantially different aqueous solubility can be simultaneously
loaded in two-phases (polymer-lipid) of these nanoparticles. In the
present proof-of-concept investigation, the particles were loaded
with two anticancer drugs: doxorubicin and curcumin as model anticancer
drugs with relatively high and low aqueous solubility, respectively.
However, there are no obstacles for loading any hydrophobic or hydrophilic
chemical agents. Nanoparticles with dual load were used for their
local inhalation delivery directly to the lungs of mice with orthotopic
model of human lung cancer. In vivo experiments showed that the selected
nanoparticles with two anticancer drugs with different mechanisms
of action prevented progression of lung tumors. It should be stressed
that anticancer effects of the combined treatment with two anticancer
drugs loaded in the same nanoparticle significantly exceeded the effect
of either drug loaded in similar nanoparticles alone.